文献速递新生儿儿童心血管与肾脏

茶碱与氨茶碱预防新生儿及儿童急性肾损伤的系统综述

Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review.
PubMed 文献 · Arch Dis Child · 2019-02-23

该系统综述与meta分析纳入9项试验,其中6项试验共436例接受单剂茶碱的足月重度出生窒息新生儿显示,茶碱使急性肾损伤(AKI)发生率降低60%(RR 0.40,95%CI 0.3-0.54,I²=0%),但不影响全因死亡率(RR 0.88,95%CI 0.52-1.50,I²=0%)。结论认为单剂预防性茶碱有助于预防重度出生窒息足月新生儿的AKI/严重肾功能不全,且不增加并发症风险。

要点

  • 单剂茶碱使重度出生窒息足月新生儿AKI发生率降低60%(RR 0.40,95%CI 0.3-0.54)。
  • 茶碱未显著影响全因死亡率(RR 0.88,95%CI 0.52-1.50)。
  • 茶碱组负液体平衡、GFR增加及尿β2微球蛋白降低方面显著更优。

核心结论

  • 单剂预防性茶碱有助于预防重度出生窒息足月新生儿的AKI/严重肾功能不全(中等质量证据),不增加并发症风险且不影响全因死亡率(极低质量证据)。

研究设计与样本

  • 系统综述与meta分析,采用GRADE系统评价证据质量。
  • 检索PubMed/MEDLINE、Embase、Google Scholar及Cochrane肾脏组,时间范围为1970年至2018年5月。
  • 纳入比较预防性茶碱或氨茶碱预防新生儿及儿童AKI疗效与安全性的随机临床试验和半随机试验。
  • 定性合成共纳入9项试验;meta分析最终纳入6项试验,共436例接受单剂茶碱的足月出生窒息新生儿。

主要发现

  • 合并估计显示重度出生窒息新生儿AKI发生率降低60%(RR 0.40;95%CI 0.3至0.54;异质性I²=0%)(中等质量证据)。
  • 茶碱组第2-5天血清肌酐下降(极低至低质量证据)。
  • 全因死亡率无显著差异(RR 0.88;95%CI 0.52至1.50;异质性I²=0%)(极低质量证据)。
  • 茶碱组在负液体平衡、GFR增加及尿β2微球蛋白降低方面显著更优。

关键数值与推荐

  • 主要结局为AKI发生率、血清肌酐水平及全因死亡率。

临床怎么用

  • 对于重度出生窒息的足月新生儿,可考虑单剂预防性茶碱以降低AKI风险,但需权衡极低质量证据支持的死亡率结局。

局限性

  • meta分析仅纳入6项试验共436例足月出生窒息新生儿,样本量有限。
  • 血清肌酐及全因死亡率结局的证据质量分别为极低至低质量和极低质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the efficacy and safety of theophylline or aminophylline for prevention of acute kidney injury (AKI) in neonates and children. DESIGN: Systematic review and meta-analysis with application of Grading of Recommendations, Assessment, Development and Evaluation system. DATA SOURCES: PubMed/MEDLINE, Embase, Google Scholar and Cochrane renal group were searched from 1970 to May 2018. ELIGIBILITY CRITERIA: Randomised clinical trials and quasi-randomised trials comparing the efficacy and safety of prophylactic theophylline or aminophylline for prevention of AKI in neonates and children were included. The primary outcomes were: incidence of AKI, serum creatinine levels and all-cause mortality. RESULTS: A total of nine trials were included in the qualitative synthesis. Six trials including 436 term neonates with birth asphyxia who received a single dose of theophylline were finally included in the meta-analysis. The pooled estimate showed 60% reduction in the incidence of AKI in neonates with severe birth asphyxia (RR: 0.40; 95% CI 0.3 to 0.54; heterogeneity: I2=0%) (moderate quality evidence), decrease in serum creatinine over days 2-5 (very low to low quality evidence) without significant difference in all-cause mortality (RR: 0.88; 95% CI 0.52 to 1.50; heterogeneity: I2=0%) (very low-quality evidence). A significant difference in the negative fluid balance, increase in GFR and decrease in urinary β2 microglobulin was seen in favour of theophylline. CONCLUSION AND RELEVANCE: A single dose of prophylactic theophylline helps in prevention of AKI/severe renal dysfunction in term neonates with severe birth asphyxia (moderate quality evidence) without increasing the risk of complications and without affecting all-cause mortality (very low-quality evidence). TRIAL REGISTRATION NUMBER: CRD 42017073600.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Bhatt GC, Gogia P, Bitzan M, et al. Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review. Arch Dis Child. 2019. PMID: 30798259. doi:10.1136/archdischild-2018-315805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。